Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.

Lee PY, Schulert GS, Canna SW, Huang Y, Sundel J, Li Y, Hoyt KJ, Blaustein RB, Wactor A, Do T, Halyabar O, Chang MH, Dedeoglu F, Case SM, Meidan E, Lo MS, Sundel RP, Richardson ET, Newburger JW, Hershfield MS, Son MB, Henderson LA, Nigrovic PA.

Ann Rheum Dis. 2019 Nov 9. pii: annrheumdis-2019-216030. doi: 10.1136/annrheumdis-2019-216030. [Epub ahead of print]

PMID:
31707357
2.

Initial Results from a Pilot Comparative Effectiveness Study of Three Methotrexate-Based Consensus Treatment Plans for Juvenile Localized Scleroderma.

Li SC, Torok KS, Rabinovich CE, Dedeoglu F, Becker ML, Ferguson PJ, Hong SD, Ibarra MF, Stewart K, Pope E, Higgins GC, Laxer RM, Mason T 2nd, Fuhlbrigge RC, Andrews T; CARRA Registry Investigators .

J Rheumatol. 2019 Oct 15. pii: jrheum.190311. doi: 10.3899/jrheum.190311. [Epub ahead of print]

PMID:
31615917
3.

Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.

Li SC, Fuhlbrigge RC, Laxer RM, Pope E, Ibarra MF, Stewart K, Mason T 2nd, Becker ML, Hong S, Dedeoglu F, Torok KS, Rabinovich CE, Ferguson PJ, Punaro M, Feldman BM, Andrews T, Higgins GC; CARRA Registry Investigators.

Pediatr Rheumatol Online J. 2019 Jul 15;17(1):43. doi: 10.1186/s12969-019-0350-5.

4.

Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.

Son MBF, Gauvreau K, Tremoulet AH, Lo M, Baker AL, de Ferranti S, Dedeoglu F, Sundel RP, Friedman KG, Burns JC, Newburger JW.

J Am Heart Assoc. 2019 Jun 4;8(11):e011319. doi: 10.1161/JAHA.118.011319.

5.

Screening and Counseling for Alcohol Use in Adolescents With Chronic Medical Conditions in the Ambulatory Setting.

Lunstead J, Weitzman ER, Harstad E, Dedeoglu F, Gaffin JM, Garvey KC, MacGinnitie A, Rufo PA, Fishman LN, Wisk LE, Levy S.

J Adolesc Health. 2019 Jun;64(6):804-806. doi: 10.1016/j.jadohealth.2019.02.011.

PMID:
31122509
6.

Classification criteria for autoinflammatory recurrent fevers.

Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. Review.

PMID:
31018962
7.

Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.

Halyabar O, Chang MH, Schoettler ML, Schwartz MA, Baris EH, Benson LA, Biggs CM, Gorman M, Lehmann L, Lo MS, Nigrovic PA, Platt CD, Priebe GP, Rowe J, Sundel RP, Surana NK, Weinacht KG, Mann A, Yuen JC, Meleedy-Rey P, Starmer A, Banerjee T, Dedeoglu F, Degar BA, Hazen MM, Henderson LA.

Pediatr Rheumatol Online J. 2019 Feb 14;17(1):7. doi: 10.1186/s12969-019-0309-6.

8.

Vasculitis in Systemic Autoinflammatory Diseases.

Demir S, Sag E, Dedeoglu F, Ozen S.

Front Pediatr. 2018 Dec 3;6:377. doi: 10.3389/fped.2018.00377. eCollection 2018. Review.

9.

Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.

Baris HE, Anderson E, Sozeri B, Dedeoglu F.

Clin Rheumatol. 2018 Dec;37(12):3263-3273. doi: 10.1007/s10067-018-4297-6. Epub 2018 Sep 20.

PMID:
30238379
10.

Using Smartphone Crowdsourcing to Redefine Normal and Febrile Temperatures in Adults: Results from the Feverprints Study.

Hausmann JS, Berna R, Gujral N, Ayubi S, Hawkins J, Brownstein JS, Dedeoglu F.

J Gen Intern Med. 2018 Dec;33(12):2046-2047. doi: 10.1007/s11606-018-4610-8. No abstract available.

PMID:
30105481
11.

In silico validation of the Autoinflammatory Disease Damage Index.

Ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler S, Brogan PA, Cantarini L, Cattalini M, Cochino AV, de Benedetti F, Dedeoglu F, de Jesus AA, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Kone-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Özen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Schulert G, Gattorno M, Frenkel J.

Ann Rheum Dis. 2018 Nov;77(11):1599-1605. doi: 10.1136/annrheumdis-2018-213725. Epub 2018 Aug 4.

PMID:
30077992
12.

De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome.

Torres A, Brownstein CA, Tembulkar SK, Graber K, Genetti C, Kleiman RJ, Sweadner KJ, Mavros C, Liu KX, Smedemark-Margulies N, Maski K, Yang E, Agrawal PB, Shi J, Beggs AH, D'Angelo E, Lincoln SH, Carroll D, Dedeoglu F, Gahl WA, Biggs CM, Swoboda KJ, Berry GT, Gonzalez-Heydrich J.

Mol Genet Metab Rep. 2018 Jun 15;16:23-29. doi: 10.1016/j.ymgmr.2018.06.001. eCollection 2018 Sep.

13.

An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA).

Vanoni F, Federici S, Antón J, Barron KS, Brogan P, De Benedetti F, Dedeoglu F, Demirkaya E, Hentgen V, Kallinich T, Laxer R, Russo R, Toplak N, Uziel Y, Martini A, Ruperto N, Gattorno M, Hofer M; for Eurofever and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Pediatr Rheumatol Online J. 2018 Apr 18;16(1):27. doi: 10.1186/s12969-018-0246-9.

14.

Adding patient-reported outcomes to a multisite registry to quantify quality of life and experiences of disease and treatment for youth with juvenile idiopathic arthritis.

Weitzman ER, Wisk LE, Salimian PK, Magane KM, Dedeoglu F, Hersh AO, Kimura Y, Mandl KD, Ringold S, Natter M.

J Patient Rep Outcomes. 2018;2. pii: 16. doi: 10.1186/s41687-017-0025-2. Epub 2018 Jan 4.

15.

The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey.

Jeyaratnam J, Ter Haar NM, Lachmann HJ, Kasapcopur O, Ombrello AK, Rigante D, Dedeoglu F, Baris EH, Vastert SJ, Wulffraat NM, Frenkel J.

Pediatr Rheumatol Online J. 2018 Mar 21;16(1):19. doi: 10.1186/s12969-018-0235-z.

16.

Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal Lesions.

Zhao Y, Wu EY, Oliver MS, Cooper AM, Basiaga ML, Vora SS, Lee TC, Fox E, Amarilyo G, Stern SM, Dvergsten JA, Haines KA, Rouster-Stevens KA, Onel KB, Cherian J, Hausmann JS, Miettunen P, Cellucci T, Nuruzzaman F, Taneja A, Barron KS, Hollander MC, Lapidus SK, Li SC, Ozen S, Girschick H, Laxer RM, Dedeoglu F, Hedrich CM, Ferguson PJ; Chronic Nonbacterial Osteomyelitis/Chronic Recurrent Multifocal Osteomyelitis Study Group and the Childhood Arthritis and Rheumatology Research Alliance Scleroderma, Vasculitis, Autoinflammatory and Rare Diseases Subcommittee.

Arthritis Care Res (Hoboken). 2018 Aug;70(8):1228-1237. doi: 10.1002/acr.23462. Epub 2018 Jul 12. Review.

17.

Human RELA haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulceration.

Badran YR, Dedeoglu F, Leyva Castillo JM, Bainter W, Ohsumi TK, Bousvaros A, Goldsmith JD, Geha RS, Chou J.

J Exp Med. 2017 Jul 3;214(7):1937-1947. doi: 10.1084/jem.20160724. Epub 2017 Jun 9.

18.

Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline z Scores.

Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, Lo MS, Baker AL, Sundel RP, Newburger JW.

J Am Heart Assoc. 2017 May 31;6(6). pii: e005378. doi: 10.1161/JAHA.116.005378.

19.

Physicians' perspectives on the diagnosis and management of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome.

Manthiram K, Li SC, Hausmann JS, Amarilyo G, Barron K, Kim H, Nativ S, Lionetti G, Zeft A, Goldsmith D, Kimberlin D, Edwards K, Dedeoglu F, Lapidus S; Childhood Arthritis and Rheumatology Research Alliance (CARRA) PFAPA Subcommittee.

Rheumatol Int. 2017 Jun;37(6):883-889. doi: 10.1007/s00296-017-3688-3. Epub 2017 Mar 7.

PMID:
28271158
20.

Physicians' Perspectives on the Diagnosis and Treatment of Chronic Nonbacterial Osteomyelitis.

Zhao Y, Dedeoglu F, Ferguson PJ, Lapidus SK, Laxer RM, Bradford MC, Li SC.

Int J Rheumatol. 2017;2017:7694942. doi: 10.1155/2017/7694942. Epub 2017 Jan 10.

21.

Development of the autoinflammatory disease damage index (ADDI).

Ter Haar NM, Annink KV, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler SM, Brogan PA, Cantarini L, Cattalini M, Cochino AV, De Benedetti F, Dedeoglu F, De Jesus AA, Della Casa Alberighi O, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Koné-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Ozen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Gattorno M, Frenkel J.

Ann Rheum Dis. 2017 May;76(5):821-830. doi: 10.1136/annrheumdis-2016-210092. Epub 2016 Nov 3.

22.

Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS).

Kuemmerle-Deschner JB, Ozen S, Tyrrell PN, Kone-Paut I, Goldbach-Mansky R, Lachmann H, Blank N, Hoffman HM, Weissbarth-Riedel E, Hugle B, Kallinich T, Gattorno M, Gul A, Ter Haar N, Oswald M, Dedeoglu F, Cantarini L, Benseler SM.

Ann Rheum Dis. 2017 Jun;76(6):942-947. doi: 10.1136/annrheumdis-2016-209686. Epub 2016 Oct 4. Review.

PMID:
27707729
23.

Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution.

Zeft AS, Prahalad S, Schneider R, Dedeoglu F, Weiss PF, Grom AA, Mix C, Pope Rd CA.

Clin Exp Rheumatol. 2016 Sep-Oct;34(5):946-952. Epub 2016 Sep 1.

PMID:
27607024
24.

A Screening Tool for Assessing Alcohol Use Risk among Medically Vulnerable Youth.

Levy S, Dedeoglu F, Gaffin JM, Garvey KC, Harstad E, MacGinnitie A, Rufo PA, Huang Q, Ziemnik RE, Wisk LE, Weitzman ER.

PLoS One. 2016 May 26;11(5):e0156240. doi: 10.1371/journal.pone.0156240. eCollection 2016.

25.

Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas.

Batu ED, Kara Eroğlu F, Tsoukas P, Hausmann JS, Bilginer Y, Kenna MA, Licameli GR, Fuhlbrigge RC, Özen S, Dedeoğlu F.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1859-1865. doi: 10.1002/acr.22901.

26.

Next-Generation Sequencing Reveals Restriction and Clonotypic Expansion of Treg Cells in Juvenile Idiopathic Arthritis.

Henderson LA, Volpi S, Frugoni F, Janssen E, Kim S, Sundel RP, Dedeoglu F, Lo MS, Hazen MM, Beth Son M, Mathieu R, Zurakowski D, Yu N, Lebedeva T, Fuhlbrigge RC, Walter JE, Nee Lee Y, Nigrovic PA, Notarangelo LD.

Arthritis Rheumatol. 2016 Jul;68(7):1758-68. doi: 10.1002/art.39606.

27.

Autoinflammatory diseases in pediatrics.

Hausmann JS, Dedeoglu F.

Dermatol Clin. 2013 Jul;31(3):481-94. doi: 10.1016/j.det.2013.04.003. Epub 2013 Jun 2. Review.

PMID:
23827250
28.

Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.

Kentsis A, Shulman A, Ahmed S, Brennan E, Monuteaux MC, Lee YH, Lipsett S, Paulo JA, Dedeoglu F, Fuhlbrigge R, Bachur R, Bradwin G, Arditi M, Sundel RP, Newburger JW, Steen H, Kim S.

EMBO Mol Med. 2013 Feb;5(2):210-20. doi: 10.1002/emmm.201201494. Epub 2012 Dec 20.

29.

Pediatric chronic nonbacterial osteomyelitis.

Borzutzky A, Stern S, Reiff A, Zurakowski D, Steinberg EA, Dedeoglu F, Sundel RP.

Pediatrics. 2012 Nov;130(5):e1190-7. doi: 10.1542/peds.2011-3788. Epub 2012 Oct 15.

PMID:
23071213
30.

Long-term surgical outcomes of adenotonsillectomy for PFAPA syndrome.

Licameli G, Lawton M, Kenna M, Dedeoglu F.

Arch Otolaryngol Head Neck Surg. 2012 Oct;138(10):902-6. doi: 10.1001/2013.jamaoto.313.

PMID:
23069819
31.

Multiple juvenile idiopathic arthritis subtypes demonstrate proinflammatory IgG glycosylation.

Ercan A, Barnes MG, Hazen M, Tory H, Henderson L, Dedeoglu F, Fuhlbrigge RC, Grom A, Holm IA, Kellogg M, Kim S, Adamczyk B, Rudd PM, Son MB, Sundel RP, Foell D, Glass DN, Thompson SD, Nigrovic PA.

Arthritis Rheum. 2012 Sep;64(9):3025-33. doi: 10.1002/art.34507.

32.

Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma.

Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, Rabinovich CE, Laxer RM, Higgins GC, Ferguson PJ, Lasky A, Baszis K, Becker M, Campillo S, Cartwright V, Cidon M, Inman CJ, Jerath R, O'Neil KM, Vora S, Zeft A, Wallace CA, Ilowite NT, Fuhlbrigge RC; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Localized Scleroderma Workgroup.

Arthritis Care Res (Hoboken). 2012 Aug;64(8):1175-85. doi: 10.1002/acr.21687.

33.

A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.

Samkari A, Borzutzky A, Fermo E, Treaba DO, Dedeoglu F, Altura RA.

Pediatrics. 2010 Apr;125(4):e964-8. doi: 10.1542/peds.2009-1774. Epub 2010 Mar 1.

PMID:
20194276
34.

Drug-induced autoimmunity.

Dedeoglu F.

Curr Opin Rheumatol. 2009 Sep;21(5):547-51. doi: 10.1097/BOR.0b013e32832f13db. Review.

PMID:
19593142
35.

Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.

Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP.

Arthritis Rheum. 2009 Jun;60(6):1825-1830. doi: 10.1002/art.24571.

36.

NOD2-associated diseases: Bridging innate immunity and autoinflammation.

Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F.

Clin Immunol. 2010 Mar;134(3):251-61. doi: 10.1016/j.clim.2009.05.005. Epub 2009 May 24. Review.

PMID:
19467619
37.

Chronic minocycline-induced autoimmunity in children.

El-Hallak M, Giani T, Yeniay BS, Jacobs KE, Kim S, Sundel RP, Dedeoglu F.

J Pediatr. 2008 Sep;153(3):314-9. doi: 10.1016/j.jpeds.2008.03.013. Epub 2008 Apr 28.

PMID:
18534244
38.

Vasculitis in children.

Dedeoglu F, Sundel RP.

Rheum Dis Clin North Am. 2007 Aug;33(3):555-83.

PMID:
17936177
39.

B-cell receptor cross-linking delays activation-induced cytidine deaminase induction and inhibits class-switch recombination to IgE.

Jabara HH, Chaudhuri J, Dutt S, Dedeoglu F, Weng Y, Murphy MM, Franco S, Alt FW, Manis J, Geha RS.

J Allergy Clin Immunol. 2008 Jan;121(1):191-196.e2. Epub 2007 Sep 27.

PMID:
17900678
40.

Update on pediatric vasculitis.

Kim S, Dedeoglu F.

Curr Opin Pediatr. 2005 Dec;17(6):695-702. Review.

PMID:
16282773
41.

Coronary artery dilation among patients presenting with systemic-onset juvenile idiopathic arthritis.

Binstadt BA, Levine JC, Nigrovic PA, Gauvreau K, Dedeoglu F, Fuhlbrigge RC, Weindling SN, Newburger JW, Sundel RP.

Pediatrics. 2005 Jul;116(1):e89-93. Epub 2005 Jun 1.

PMID:
15930186
42.

Vasculitis in children.

Dedeoglu F, Sundel RP.

Pediatr Clin North Am. 2005 Apr;52(2):547-75, vii. Review.

PMID:
15820379
43.

TACI and BAFF-R mediate isotype switching in B cells.

Castigli E, Wilson SA, Scott S, Dedeoglu F, Xu S, Lam KP, Bram RJ, Jabara H, Geha RS.

J Exp Med. 2005 Jan 3;201(1):35-9.

44.

Impaired IgA class switching in APRIL-deficient mice.

Castigli E, Scott S, Dedeoglu F, Bryce P, Jabara H, Bhan AK, Mizoguchi E, Geha RS.

Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3903-8. Epub 2004 Feb 26.

45.

Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB.

Dedeoglu F, Horwitz B, Chaudhuri J, Alt FW, Geha RS.

Int Immunol. 2004 Mar;16(3):395-404.

PMID:
14978013
46.

Targeted inactivation of the IL-4 receptor alpha chain I4R motif promotes allergic airway inflammation.

Blaeser F, Bryce PJ, Ho N, Raman V, Dedeoglu F, Donaldson DD, Geha RS, Oettgen HC, Chatila TA.

J Exp Med. 2003 Oct 20;198(8):1189-200. Epub 2003 Oct 13.

47.

The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

Jabara H, Laouini D, Tsitsikov E, Mizoguchi E, Bhan A, Castigli E, Dedeoglu F, Pivniouk V, Brodeur S, Geha R.

Immunity. 2002 Sep;17(3):265-76.

48.

Successful treatment of retroperitoneal fibrosis with tamoxifen in a child.

Dedeoglu F, Rose CD, Athreya BH, Conard K, Grissom L, Magnusson M.

J Rheumatol. 2001 Jul;28(7):1693-5.

PMID:
11469481
49.

Cross-reactions of anti-immunoglobulin sera with synthetic T-cell receptor beta peptides: mapping on a 3-dimension model.

Kaymaz H, Dedeoglu F, Schluter SF, Edmundson AB, Marchalonis JJ.

Adv Exp Med Biol. 1994;347:93-8.

PMID:
7526639
50.

Light and heavy chains specifying a human IgM kappa autoantibody to a T-cell receptor V beta-antigen.

Dedeoglu F, Kaymaz H, Klein G, Marchalonis JJ.

Immunol Lett. 1993 Nov;38(3):223-7.

PMID:
8125530

Supplemental Content

Loading ...
Support Center